Massachusetts General Hospital: Glioblastoma trials

The registry lists 15 Glioblastoma studies with Massachusetts General Hospital as lead sponsor. 1 are open to participants now and 7 have results posted.

Early Phase 1 3Phase 1 2Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• G-CSF After Chemo-radiation in Patients With GlioblastomaRecruitingNCT06649851Phase 2
• Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed GlioblastomaCompletedNCT03139916Phase 2Results posted
• A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or ImmunotherapyCompletedNCT02431572Not applicableResults posted
• FMISO PET Study of GlioblastomaCompletedNCT02076152Not applicableResults posted
• Bevacizumab w / Temozolomide PET & Vascular MRI For GBMCompletedNCT01987830Not applicableResults posted
• Tivozanib for Recurrent GlioblastomaCompletedNCT01846871Phase 2Results posted
• Bosutinib in Adult Patients With Recurrent GlioblastomaCompletedNCT01331291Phase 2Results posted
• MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaTerminatedNCT00756106Not applicableResults posted
• Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRICompletedNCT02843230
• MET-PET for Newly Diagnosed GlioblastomaCompletedNCT01867593Early Phase 1
• PF-00299804 in Adult Patients With Relapsed/Recurrent GlioblastomaCompletedNCT01112527Phase 2
• Evaluating Tumor Pseudoprogression With FLT-PET and MRITerminatedNCT01105988Early Phase 1
• Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent GlioblastomaCompletedNCT00864864Early Phase 1
• Vandetanib and Sirolimus in Patients With Recurrent GlioblastomaCompletedNCT00821080Phase 1
• PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic DrugsCompletedNCT00385853Phase 1